Extremities Hospitals Anika Therapeutics Files Investigational Device Exemption to Initiate Phase III Study to Expand Indication of MONOVISC® to Treat Pain Caused by Osteoarthritis of the Hip byJosh SandbergJune 23, 2015
Financial Anika Therapeutics Announces Date of First-Quarter 2015 Financial Results Conference Call byJosh SandbergApril 17, 2015
